-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/9Ks34K-BnsDSBK4MYDATYS
August 09, 2016 - Familial hypercholesterolemia and other monogenic condi-
tions were excluded from this review, as were renal … Sexual maturation was evaluated at every visit through year 5 or
until the participant reached Tanner stage … At the end of the
study, 283 participants (3.1%) had died.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-7-tables1.xls
August 25, 2011 - Ingredient, Age, Gender, and Race
Note: A dash signifies a small cell count (less than 11); ESRD = end … stage renal disease.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-7-tables.xls
August 25, 2011 - Ingredient, Age, Gender, and Race
Note: A dash signifies a small cell count (less than 11); ESRD = end … stage renal disease.
-
hcup-us.ahrq.gov/reports/methods/2006_9.pdf
January 01, 2006 - The remaining sample of hospitals was based on a stratified,
three-stage design:
1. … The second stage consisted of selecting non-certainty hospitals from the sampled PSUs. … During the third and final stage, a sample of discharges was selected by systematic
random sampling … At the other end of the spectrum, only four of the 10 least
populous states were included in the NIS … (5)
160** 1.34
(0.02)
1.29* 6.12
(0.05)
6.23* 0.00
(0.00)
0.001 $25,643
(711)
$25,362
316: Renal
-
hcup-us.ahrq.gov/db/nation/nis/reports/2002niscomparisonrpt.jsp
June 01, 2016 - The remaining sample of hospitals was based on a stratified, three-stage design:
The first stage … The second stage consisted of selecting non-certainty hospitals from the sampled PSUs. … During the third and final stage, a sample of discharges was selected by systematic random sampling techniques … At the other end of the spectrum, only two of the 10 least populous states were included in the NIS: … 1.07
4.45 (0.06)
4.37
0.93 (0.07)
0.95
$22,015 (709)
$21,111
316: renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
July 01, 2012 - At the end of the initial patient visit and following resolution of any drug related
problems, the MTM … Mellitus □ Hypokalemia
□ Atrial Fib/Atrial Flutter □ DVT/PE □ Kidney Transplant
□ Chronic Renal … _ / ___ ___ / ___ ___
□ Yes □ No
___ ___ / ___ ___ / ___ ___
□ Yes □ No
END
-
hcup-us.ahrq.gov/reports/methods/2005_03_del_379.pdf
January 01, 2005 - The remaining sample of hospitals was based on a stratified,
three-stage design:
1. … The second stage consisted of selecting non-certainty hospitals from the sampled PSUs. … During the third and final stage, a sample of discharges was selected by systematic
random sampling … At the other end of the spectrum, only two of the 10 least
populous states were included in the NIS: … 143
(6)
124** 1.03
(0.03)
1.07 4.45
(0.06)
4.37 0.93
(0.07)
0.95 $22,015
(709)
$21,111
316: renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
August 27, 2012 - The first use of much of this dates back
60 years or more (to the end of the WWII), so you might
indicate … No papers discussing end stage renal
disease or cystic fibrosis were eligible for
inclusion. … depression...I think the findings
are that women were receiving better care at baseline,
and that by the end … The
take home message from this report for me is much more
like: “At this stage, and with the available
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
August 27, 2012 - The first use of much of this dates back
60 years or more (to the end of the WWII), so you might
indicate … No papers discussing end stage renal
disease or cystic fibrosis were eligible for
inclusion. … depression...I think the findings
are that women were receiving better care at baseline,
and that by the end … The
take home message from this report for me is much more
like: “At this stage, and with the available
-
pbrn.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
pcmh.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
healthcare411.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
cahps.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
preventiveservices.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
hcup-us.ahrq.gov/reports/methods/2019-01.pdf
January 01, 2019 - The AHRQ QI measures generated for possible inclusion in the QDR are described in Table 1
at the end … the AHRQ PQI software, diabetes must be the
principal diagnosis and long-term complications include renal … Exclusions include the
following: admissions with a diagnosis code for chronic renal
failure and transfers … software, the following cases are excluded: admissions with
a principal diagnosis of pressure ulcer stage … with the AHRQ PSI software, the following cases are excluded:
obstetric cases; admissions with acute renal
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/oPmYxryXGu2occANaReagc
August 01, 2022 - Related article at
jamanetworkopen.com
Author Affiliations: Author
affiliations are listed at the end … Diagram: Screening for Latent Tuberculosis Infection in Adults
3275 Excluded at title and abstract stage … 413 Excluded at title and abstract stage
188 Wrong population
48 Wrong intervention
45 Wrong study … (53 included studies) used a mixed-
treatment comparison methodology and focused on 2 prespecified
end … household or close contacts of persons with
active tuberculosis without confirmed LTBI; and persons with renal
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps/diagnosis-improvement/dxsafety-facilitators-guide.pdf
February 04, 2022 - This reality-based case describes the diagnostic journey of a 49-year-old patient, Joe Kane, with
end … stage renal disease who is receiving weekly hemodialysis. … Add your Overall Ratings into a Summary Score at the end
of the assessment; the range is from 0 to 125 … Summary Score: Add your Overall Rating for each domain into a total score at the end.
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dxsafety-facilitators-guide.pdf
February 04, 2022 - This reality-based case describes the diagnostic journey of a 49-year-old patient, Joe Kane, with
end … stage renal disease who is receiving weekly hemodialysis. … Add your Overall Ratings into a Summary Score at the end
of the assessment; the range is from 0 to 125 … Summary Score: Add your Overall Rating for each domain into a total score at the end.